🔗 Share this article

The top legal official in Texas Ken Paxton is taking legal action against the makers of Tylenol, claiming the corporations hid safety concerns that the drug posed to children's cognitive development.

The lawsuit arrives thirty days after Former President Trump advocated an unsubstantiated connection between consuming Tylenol - alternatively called paracetamol - during pregnancy and autism in young ones.

Paxton is filing suit against J&J, which previously sold the medication, the only pain reliever approved for women during pregnancy, and Kenvue, which presently makes it.

In a declaration, he claimed they "misled consumers by making money from discomfort and marketing drugs without regard for the potential hazards."

The company asserts there is insufficient reliable data tying acetaminophen to autism spectrum disorder.

"These manufacturers misled for generations, deliberately risking numerous people to line their pockets," the attorney general, from the Republican party, said.

Kenvue commented that it was "seriously troubled by the dissemination of inaccurate information on the reliability of acetaminophen and the possible consequences that could have on the well-being of women and children in America."

On its official site, Kenvue also said it had "regularly reviewed the applicable studies and there is no credible data that shows a established connection between consuming acetaminophen and autism."

Groups representing medical professionals and medical practitioners share this view.

The leading OB-GYN organization has stated acetaminophen - the primary component in acetaminophen - is a restricted selection for women during pregnancy to manage discomfort and elevated temperature, which can present significant medical dangers if not addressed.

"In over twenty years of investigation on the utilization of paracetamol in pregnancy, no reliable research has successfully concluded that the usage of paracetamol in any period of pregnancy causes neurodevelopmental disorders in children," the association said.

This legal action cites current declarations from the previous government in asserting the drug is allegedly unsafe.

Recently, Trump generated worry from medical authorities when he instructed expectant mothers to "struggle intensely" not to take acetaminophen when unwell.

The FDA then released a statement that doctors should think about restricting the usage of Tylenol, while also declaring that "a direct connection" between the medication and autism in children has not been proven.

Health Secretary Kennedy, who oversees the Food and Drug Administration, had vowed in spring to undertake "extensive scientific investigation" that would establish the source of autism in a short period.

But authorities advised that discovering a unique factor of autism spectrum disorder - believed by scientists to be the outcome of a complex mix of inherited and surrounding conditions - would be difficult.

Autism is a form of permanent neurological difference and condition that affects how people perceive and relate to the environment, and is identified using physician assessments.

In his legal document, the attorney general - a Trump ally who is running for federal office - claims the manufacturer and Johnson & Johnson "intentionally overlooked and sought to suppress the evidence" around paracetamol and autism.

The case attempts to require the companies "destroy any commercial messaging" that states acetaminophen is secure for pregnant women.

This legal action parallels the concerns of a collection of mothers and fathers of young ones with autism and ADHD who took legal action against the producers of acetaminophen in two years ago.

A federal judge rejected the legal action, declaring studies from the parents' expert witnesses was not conclusive.